Selskabets formål er at udvikle og sælge farmaceutiske produkter.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -25 t. | -23 t. | 2.8 mio. | 2.7 mio. | 0 | |
CVR: 40010114
Secondary names: Prozymex ApS, Prozymex Ltd. ApS, Prozymex Pharmaceuticals ApS
Companies in the same industry and area
Compared to 14 companies in Fremstilling af andre organiske basiskemikalier
Comparison is based on industry median values
companydata.dk